Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) France

Research

Date range: 1 August 2022 - 31 July 2023

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) published between 1 August 2022 - 31 July 2023 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)
Count Share
1 0.05

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.05

Share output for the past 5 years

Share per year
2018 2019 2020 2021 2022*
0.00 0.62 0.00 1.08 0.17

Compare Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) with other institutions

*Note: 2022 data contains Share for article affiliations from newly added health-science journals.

Nature Strategy Reports

Nature Strategy Reports gives you simple insights to support decisions that impact your organisation

The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.

Get started

Collaboration

Date range: 1 August 2022 - 31 July 2023

International vs. domestic collaboration by Share

  • 34.91% Domestic (6 institutions)
  • 65.09% International (10 institutions)

Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators with Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) by Share*

  1. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and Assistance Publique-Hôpitaux de Paris (AP-HP) (0.22)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    Assistance Publique-Hôpitaux de Paris (AP-HP)0.17
  2. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and CHU de Poitiers (0.12)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    CHU de Poitiers0.07
  3. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and CHU Limoges (0.09)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    CHU Limoges0.03
  4. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and French National Centre for Scientific Research (CNRS) (0.07)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    French National Centre for Scientific Research (CNRS)
  5. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and National Institute for Health and Medical Research (INSERM) (0.07)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    National Institute for Health and Medical Research (INSERM)
  6. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and University of Limoges (ULIM) (0.07)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    University of Limoges (ULIM)

Top 10 international collaborators with Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) by Share*

  1. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and Mayo Clinic (0.34)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    Mayo Clinic0.29
  2. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and Columbia University in the City of New York (CU) (0.19)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    Columbia University in the City of New York (CU)0.14
  3. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and CareMount Medical (0.09)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    CareMount Medical0.03
  4. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and Emory University (0.09)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    Emory University0.03
  5. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and Hackensack Meridian Health (0.09)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    Hackensack Meridian Health0.03
  6. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and Nephrology Consultants of Northwest Ohio (0.09)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    Nephrology Consultants of Northwest Ohio0.03
  7. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and The Center For Kidney Care (0.09)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    The Center For Kidney Care0.03
  8. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and Victoria Kidney and Dialysis Associates (0.09)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    Victoria Kidney and Dialysis Associates0.03
  9. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and Cornell University (0.07)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    Cornell University
  10. Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) and Memorial Sloan Kettering Cancer Center (MSKCC) (0.07)
    Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)0.05
    Memorial Sloan Kettering Cancer Center (MSKCC)

*Share is the fractional count allocated to an institution for an article that takes into account the percentage of authors from that institution and the number of affiliated institutions that contributed to the article. The horizontal stacked bar charts above indicate the Share contributed by each institution in the bilateral collaboration. If the Share is not shown, hover over the bar to display it.

Nature Careers

Need to hire scientific researchers?

Nature Careers is visited by over 180,000 active jobseekers per month that you can target directly with your role. Application response rates have increased by 28% on average over 2022 averages.

Relationships

Partner Institutions

Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL) is a research collaboration whose article contributions are accrued to its participating partner institutions below.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.